Relapse is seen in over 50% of patients (1).
There is no established standard in the treatment of relapsed disease. The idea behind treatment of relapsed AML patients is to achieve a new remission.
Once a new remission has been achieved, allogeneic stem cell transplantation is the consolidation therapy of choice. An autologous HSCT is often regarded as the second best option in situations where an allogeneic HSCT is not possible due to lack of a suitable donor (2).
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.